I now have a clear, evidence-based answer. Here is the full analysis:
Betahistine (Letapin-16) - Is It Appropriate for This Patient?
What the Medicine Is
Letapin-16 contains Betahistine Dihydrochloride 16 mg, manufactured by Encore Healthcare Pvt Ltd, India. It is a histamine analogue that works by:
- Improving microvascular circulation in the stria vascularis of the cochlea (inner ear blood supply)
- Reducing endolymphatic pressure
- Inhibiting activity of the vestibular nuclei (balance centres in the brain)
What Betahistine Is Prescribed For
Betahistine is primarily used for:
- Meniere's disease - the main licensed indication (episodic vertigo + tinnitus + fluctuating hearing loss)
- Vestibular vertigo - dizziness/spinning sensation from inner ear dysfunction
- Tinnitus - ringing in the ears (though evidence is limited)
- Inner ear-related hearing fluctuation
Does It Match This Patient's Audiological Findings?
This is where it gets nuanced. Looking back at the report:
| Finding | Detail |
|---|
| Right ear | Minimal sensorineural hearing loss, high-frequency dip (2k-8k Hz) |
| Left ear | Normal hearing |
| Tympanometry | Type As bilaterally, no middle ear disease |
| MEMRs | Present |
| Audiologist's diagnosis | Minimal hearing loss, no conductive pathology |
The audiogram alone does NOT show Meniere's disease - that condition typically causes a low-frequency sensorineural loss with episodic vertigo and tinnitus. However, the audiogram is only one piece of the picture.
The ENT doctor likely prescribed Betahistine because the patient is also experiencing symptoms not captured in the audiogram - such as:
- Dizziness or vertigo episodes
- Tinnitus (ringing/buzzing in the ear)
- A sense of ear fullness
- Possible early/suspected Meniere's disease or vestibular hydrops
Is the Prescription Appropriate?
Likely yes, with context. The ENT would have taken a clinical history beyond what the audiogram shows. The Type As tympanogram and the mild right-sided sensorineural loss together could suggest early inner ear pathology, and if the patient has any accompanying vestibular symptoms (vertigo, tinnitus), betahistine is a standard first-line treatment.
However, an important evidence-based caution from the textbook:
"There is insufficient evidence from high quality randomized trials to say whether or not betahistine has any effect on Menière's. It may reduce vertigo, and possibly tinnitus, but does not seem to influence the hearing loss itself."
- Scott-Brown's Otorhinolaryngology Head & Neck Surgery
So practically:
- For vertigo/tinnitus - betahistine can help
- For the hearing loss itself - it will not reverse or improve the audiometric thresholds
- Standard dose is 16 mg three times a day (which matches the pack prescribed)
Key Precautions to Know
| Caution | Detail |
|---|
| Peptic ulcer disease | Avoid - can irritate the stomach |
| Asthma | Use with caution |
| Phaeochromocytoma | Contraindicated |
| Pregnancy/breastfeeding | Use with caution |
| Side effects | Headache, nausea, stomach upset, skin rash (uncommon) |
| Alcohol | Best avoided while taking |
Bottom Line
The prescription is medically reasonable for managing any vestibular/tinnitus component associated with this patient's inner ear condition. It will not directly restore the audiometric hearing thresholds, but if the patient has vertigo, tinnitus, or ear fullness alongside the mild sensorineural loss, betahistine is appropriate and is the standard ENT approach. Take it as directed by the ENT doctor (typically 16 mg three times daily with food).
- Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1 - Betahistine pharmacology section